Allergy immunotherapy is also known as desensitization, hyposensitization, and allergy injection therapy. It works by reducing the body’s sensitivity to allergens by immunizing it with the right antigens. Patients usually start the therapy with low doses, increasing their tolerance over a period of two to six weeks. Continuing the treatment for several years may be beneficial. In the treatment of allergic conditions, Allergy Immunotherapy can be effective in reducing or eliminating the underlying allergies. The immunotherapy process consists of several steps, including allergy shots. Each step is accompanied by side effects. While allergy shots can be uncomfortable, they are typically effective in alleviating symptoms. Most patients can stop taking these shots within three to five years. However, some individuals may need to remain on their immunotherapy regimen for longer.
The global allergy immunotherapy market is estimated to be valued at US$ 2,116.0 million in 2022 and expected to exhibit a CAGR of 9.3% over the forecast period (2022-2030).
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/4915
The rising incidence and prevalence of allergic disorders is expected to aid in the growth of the global allergy immunotherapy market.
For instance, according to the Centers for Disease Control and Prevention, the U.S. recorded 19.2 million and 5.2 million cases of hay fever in adults aged 18 and over and children under age 18 years, respectively, in 2018.
Moreover, the changes in environmental conditions and increasing pollution are driving the global allergy immunotherapy market growth. For instance, according to the Asthma and Allergy Foundation of America (AAFA), about 23 million people in the U.S. have symptoms from ragweed pollen allergy. These symptoms can make life depressed for those with allergies, which can also cause asthma symptoms for allergic asthma people.
Global Allergy Immunotherapy Market: Restraint
The lack of awareness among patients about allergy immunotherapy is expected to restrain growth of the global allergy immunotherapy market. Additionally, side effects associated with allergic immunotherapy is another factor that is predicted to restrict the market growth.
Global Allergy Immunotherapy Market – Impact Analysis of COVID-19
The COVID-19 outbreak has adversely affected the allergy immunotherapy market. It has become difficult for the researchers to conduct researches during this COVID-19 pandemic. People with ragweed pollen allergy are getting confused with the COVID-19 symptoms as the symptoms associated with both conditions are similar. Thus, the overall market is estimated to observe an optimistic growth during the COVID-19 pandemic.
Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/4915
Major players operating in the global allergy immunotherapy market include Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma, HAL Allergy Group, Aimmune Therapeutics, DBV Technologies, Leti Pharma, and Jubilant HollisterStier.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Allergy Immunotherapy Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Allergy Immunotherapy Industry Impact
Chapter 2 Global Allergy Immunotherapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Allergy Immunotherapy (Volume and Value) by Type
2.3 Global Allergy Immunotherapy (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Allergy Immunotherapy Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Allergy Immunotherapy Market Analysis
Chapter 6 East Asia Allergy Immunotherapy Market Analysis
Chapter 7 Europe Allergy Immunotherapy Market Analysis
Chapter 8 South Asia Allergy Immunotherapy Market Analysis
Chapter 9 Southeast Asia Allergy Immunotherapy Market Analysis
Chapter 10 Middle East Allergy Immunotherapy Market Analysis
Chapter 11 Africa Allergy Immunotherapy Market Analysis
Chapter 12 Oceania Allergy Immunotherapy Market Analysis
Chapter 13 South America Allergy Immunotherapy Market Analysis
Chapter 14 Company Profiles and Key Figures in Allergy Immunotherapy Business
Chapter 15 Global Allergy Immunotherapy Market Forecast (2022-2028)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/4915
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027